Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 851Lung Neoplasms 575Small Cell Lung Carcinoma 164Colorectal Neoplasms 130Breast Neoplasms 104Melanoma 100Neoplasms 91Ovarian Neoplasms 89Neoplasm Metastasis 82Pancreatic Neoplasms 74Squamous Cell Carcinoma of Head and Neck 68Stomach Neoplasms 59Carcinoma, Renal Cell 54Head and Neck Neoplasms 53Esophageal Neoplasms 48Triple Negative Breast Neoplasms 47Endometrial Neoplasms 47Prostatic Neoplasms 45Uterine Cervical Neoplasms 41Colonic Neoplasms 40Urinary Bladder Neoplasms 39Mesothelioma 38Carcinoma, Hepatocellular 35Mesothelioma, Malignant 34Brain Neoplasms 30Sarcoma 28Carcinoma, Transitional Cell 28Adenocarcinoma of Lung 28Lung Diseases 24Disease 24

Interventions

X-Rays 1Tenecteplase 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pleural Effusion × Thoracic × 90 days × Clear all
NCT00761618 2026-04-16

Intrapleural Catheter Daily Versus Three Times a Week Drainage

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
257 enrolled
Thoracic

Pleural Effusion, Pleural Effusion, Malignant

NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡